semaglutide hydrogel New Hydrogel: Say Goodbye to Weekly Shots for Diabetes and Weight Loss Gelzempic' Could Make Popular Weight

Suitable candidates include: Patients with type 2 diabetes and a BMI of 35 kg/m or higher (or 32.5 kg/m or higher for people of South Asian or other minority ethnic backgrounds), or where weight loss would benefit other significant obesity-related comorbidities Those with type 2 diabetes who have not achieved target HbA1c levels with metformin and other oral medications People for whom weight loss would benefit other obesity-related comorbidities or where weight-neutral treatment options are preferred Individuals with occupational implications where insulin therapy would be problematic Importantly, NICE recommends continuing GLP-1 receptor agonist treatment only if there is a beneficial metabolic response: after 6 months, treatment should continue only if HbA1c has decreased by at least 11 mmol/mol (1.0%) and weight has decreased by at least 3% from initial body weight

For some, its distancing yourself from toxic relationships

Johansen et al

GLP-1 RAs find use in the treatment of psoriasis due to their immunological effects

This dual action produces superior weight loss outcomes in clinical trials, with nausea rates ranging from 24% to 40% depending on dose in the SURMOUNT-1 trial